Effect of Meloxicam and Profen in analgesia after mandibular impacted third molar surgery

Comparison of the Effectiveness of Meloxicam and Profen in duration of analgesia after mandibular impacted third molar surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170307032929N3

Enrollment

Registered

2020-09-18

Start date

2019-09-23

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Removal of impacted mandibular third molar. Impacted teeth

Interventions

Intervention 1: Intervention group: The patient was randomly given a 15 mg Meloxicam tablet half an hour before the start of surgery, and the patients were told they can use an volatile drug such as a

Eligibility

Sex/Gender

All

Age

17 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients in the age range of 17 to 35 Requires bilatral surgery of mandibular impacted third molar

Exclusion criteria

Exclusion criteria: Acute or chronic inflammation Taking other medications Pregnancy Contraindication of study drugs for patient Systemic problems

Design outcomes

Primary

Measure	Time frame
Duration of analgesia. Timepoint: The patient is given medicine half an hour before the start of surgery and the pain is recorded 2, 4, 6, 10, 15 hours after the surgery. Method of measurement: In the study of the effect of meloxicam and profen on duration of analgesia after mandibular impacted third molar surgery, the method of measuring the variable can be visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFina Navi

Islamic Azad University

f_navi@dentaliau.ac.ir+98 21 2256 4571

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026